Lisata Therapeutics Terminates Merger Agreement With Kuva Labs On July 24, Says SEC Filing
LSTA•Merger agreement terminated and board reviews options
July 24 (Reuters) - Lisata Therapeutics Inc LSTA.O:
- Lisata Therapeutics terminates merger agreement with Kuva Labs on July 24, 2026 - SEC filing
- Lisata Therapeutics says the termination was due to Kuva Labs' failure to obtain financing and accept tendered shares - SEC filing
- Lisata Therapeutics says its board will assess strategic options including reverse merger or asset sales - SEC filing
